Inventor · disambiguated record
Arnold Lippa
Also filed as: LIPPA ARNOLD · LIPPA ARNOLD S · LIPPA ARNOLD STAN
14 granted patents·17 pending applications·753 citations·filing 1985–2024
95Inventor score
Files withLIPPA ARNOLD S9DOV PHARMACEUTICAL INC8LIPPA ARNOLD STAN5HEARING INNOVATIONS INC3EBI LIFE SCIENCES INC2
Top patents by PatentIndex Score
31 records- 0196US6372919B1(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agentDOV PHARMACEUTICAL INC·Filed 2001·Granted Apr 16, 2002·87 cites·15 claims
- 0294US6716868B2(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2003·Granted Apr 6, 2004·41 cites·3 claims
- 0392US4777128AFluorescence immunoassay involving energy transfer between two fluorophoresETHIGEN CORP·Filed 1986·Granted Oct 11, 1988·125 cites·44 claims
- 0491US6569887B2(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptakeDOV PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·41 cites·19 claims
- 0590US7098229B2(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereofDOV PHARMACEUTICAL INC·Filed 2002·Granted Aug 29, 2006·32 cites·18 claims
- 0690US7081471B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Jul 25, 2006·24 cites·4 claims
- 0789US7098230B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Aug 29, 2006·20 cites·23 claims
- 0889US7041835B2(−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted May 9, 2006·23 cites·10 claims
- 0986US6169813B1Frequency transpositional hearing aid with single sideband modulationHEARING INNOVATIONS INC·Filed 1994·Granted Jan 2, 2001·103 cites·11 claims
- 1086US2024300931A1Composition and Methods for Treating Attention Deficit DisordersLIPPA ARNOLD STAN·Filed 2024·Application pending·0 cites
- 1183US6173062B1Frequency transpositional hearing aid with digital and single sideband modulationHEARING INNOVATIONS INC·Filed 1994·Granted Jan 9, 2001·103 cites·15 claims
- 1283US2023373982A1Compositions And Methods For Treating Attention Deficit DisordersLIPPA ARNOLD STAN·Filed 2023·Application pending·0 cites
- 1381US2023129330A1Compositions And Methods For Treating Attention Deficit DisordersLIPPA ARNOLD STAN·Filed 2022·Application pending·0 cites
- 1476US6162463AExtended release formulation of diltiazem hydrochlorideDOV PHARMACEUTICAL INC·Filed 1998·Granted Dec 19, 2000·46 cites·16 claims
- 1575US2021340130A1Compositions and methods for treating attention deficit disordersLIPPA ARNOLD STAN·Filed 2021·Application pending·0 cites
- 1668US6377693B1Tinnitus masking using ultrasonic signalsHEARING INNOVATIONS INC·Filed 1994·Granted Apr 23, 2002·103 cites·12 claims
- 1767US2024100023A1Compositions and Methods For Treating Spinal Cord InjuriesLIPPA ARNOLD S·Filed 2023·Application pending·0 cites
- 1864US2025325480A1Lipid Nanoparticle Compositions and Methods For Formulating Insoluble DrugsRESPIRERX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1962US2019112300A1Compositions And Methods For Treating Attention Deficit DisordersLIPPA ARNOLD STAN·Filed 2017·Application pending·0 cites
- 2060US9393204B2Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disordersEBI LIFE SCIENCES INC·Filed 2013·Granted Jul 19, 2016·1 cites·28 claims
- 2154US2008081781A1Methods and compositions for the treatment of metabolic syndromeLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 2251US2008081834A1Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disordersLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 2349US2008027119A1Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disordersLIPPA ARNOLD S·Filed 2005·Application pending·0 cites
- 2448US2007225351A1Methods and compositions for controlling body weight and appetiteLIPPA ARNOLD S·Filed 2006·Application pending·0 cites
- 2547US2008234354A1Methods And Compositions For Controlling Body Weight And AppetiteLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 2647US2008045547A1Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And UseLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 2747US2002172694A1Extended release formulation of diltiazem hydrochlorideDOV PHARMACEUTICAL INC·Filed 2001·Application pending·0 cites
- 2844US2007082939A1Methods and compositions for the treatment of neuropathies and related disordersLIPPA ARNOLD S·Filed 2006·Application pending·0 cites
- 2944US2006173064A1(-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disordersLIPPA ARNOLD S·Filed 2005·Application pending·0 cites
- 3039US2017165228A1Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disordersEBI LIFE SCIENCES INC·Filed 2016·Application pending·0 cites
- 3134US4857514AVirus inactivationYEDA RES & DEV·Filed 1985·Granted Aug 15, 1989·4 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Arnold Lippa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →